File Name: dementia apathy interview and rating .zip
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
- Apathy in Alzheimer's disease
- Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
- Motivation and Dementia
Apathy in Alzheimer's disease
Apathy is the most common neuropsychiatric symptom in patients with Alzheimer's disease AD. The presence of apathy has been related to greater caregiver distress, decreased quality of life, and increased morbidity. Here we review the most recent studies on this neuropsychiatric syndrome, focusing on prevalence, impact on quality of life, behavioural and neuroimaging studies, and treatment options. The results of some investigations on the behavioural and neuroanatomical profile of apathy in AD point to a role of frontostriatal circuits, specifically involving the anterior cingulate cortex. However, small and heterogeneous samples, lack of control for disease severity, and non-specific apathy scales complicate interpretation of results. Future studies might benefit from studying multiple dimensions of apathy within conceptual frameworks which allow for a deconstruction of underlying mechanisms.
Metrics details. Apathy, which can be defined as a lack of motivation, is one of the most prevalent neuropsychiatric symptoms in AD and typically leads to a worse quality of life and greater burden for caregivers. Treatment options for apathy in AD are limited, but studies have examined the use of the amphetamine, methylphenidate. The Apathy in Dementia Methylphenidate Trial ADMET found that treatment of apathy in AD with methylphenidate was associated with significant improvement in apathy in two of three outcome measures, some evidence of improvement in global cognition, and minimal adverse events. A larger, longer-lasting trial is required to confirm these promising findings.
Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
Join NursingCenter to get uninterrupted access to this Article. When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article. Lack of motivation and apathy are frequent problems in the rehabilitation of persons with dementia. Apathy is related to lower functional ability and poor relationships with caregivers. While related to depression, apathy presents separate challenges.
Interviews for caregiver detection and therefore more accurate diagnosis of apathy. Dementia. Dementia Apathy Interview and. Rating (DAIR).  Strauss.
Motivation and Dementia
Self-rated apathy, depression, and anxiety rating scales were also administered. Psychosis hallucinations and delusions increased from Risk factors for the development of PD-MCI include older age at disease onset, male gender, depression, severity of motor symptoms, and advanced disease stage [ 4 ].